These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7084486

  • 41. The Franz Gross Memorial Lecture. The renin-aldosterone connection: past, present and future.
    Robertson JI.
    J Hypertens Suppl; 1984 Dec; 2(3):S1-14. PubMed ID: 6400362
    [No Abstract] [Full Text] [Related]

  • 42. Secondary aldosteronism.
    Corry DB, Tuck ML.
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):511-29. PubMed ID: 8575407
    [Abstract] [Full Text] [Related]

  • 43. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P, Turgeon A, García R, Schiffrin EL.
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [Abstract] [Full Text] [Related]

  • 44. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J.
    Ann Acad Med Stetin; 1996 Jan; 42():123-38. PubMed ID: 9199117
    [Abstract] [Full Text] [Related]

  • 45. Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: effect of chronic caffeine ingestion.
    Kost CK, Li P, Pfeifer CA, Jackson EK.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1063-70. PubMed ID: 7932154
    [Abstract] [Full Text] [Related]

  • 46. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP, Schnackenberg CG.
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [Abstract] [Full Text] [Related]

  • 47. Mineralocorticoid resistance.
    Geller DS.
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [Abstract] [Full Text] [Related]

  • 48. [Role of vasopressin in arterial hypertension].
    Thibonnier M, Sassano P, Daufresne S, Menard J.
    Nouv Presse Med; 1982 Oct 09; 11(39):2915-20. PubMed ID: 7145678
    [Abstract] [Full Text] [Related]

  • 49. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T, Hanon O, Mounier-Vehier C, Marquand A, Fauvel JP, Laurent P, Tison E, Equine O, Ducloux D, Girerd X.
    Arch Mal Coeur Vaiss; 2000 Aug 09; 93(8):1037-9. PubMed ID: 10989753
    [Abstract] [Full Text] [Related]

  • 50. [Kidney and hypertension].
    Menne J, Fliser D, Haller H.
    Herz; 2006 Jun 09; 31(4):317-21. PubMed ID: 16810471
    [Abstract] [Full Text] [Related]

  • 51. Malignant hypertension - the role of the paracrine renin-angiotensin system.
    Fleming S.
    J Pathol; 2000 Oct 09; 192(2):135-9. PubMed ID: 11004688
    [Abstract] [Full Text] [Related]

  • 52. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats.
    Liu KL.
    Clin Exp Pharmacol Physiol; 2009 May 09; 36(5-6):455-61. PubMed ID: 19215237
    [Abstract] [Full Text] [Related]

  • 53. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr 09; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

  • 54. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats.
    Kalaitzis C, Touloupidis S, Bantis E, Patris E, Triantafyllidis A.
    Scand J Urol Nephrol; 2005 Apr 09; 39(1):15-20. PubMed ID: 15764265
    [Abstract] [Full Text] [Related]

  • 55. Hypertension: a critical survey.
    Grollman A.
    Pathobiol Annu; 1980 Apr 09; 10():269-303. PubMed ID: 7003496
    [No Abstract] [Full Text] [Related]

  • 56. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug 09; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

  • 57. Pathophysiology of experimental renovascular hypertension.
    Nabel EG, Gibbons GH, Dzau VJ.
    Am J Kidney Dis; 1985 Apr 09; 5(4):A111-9. PubMed ID: 3887899
    [Abstract] [Full Text] [Related]

  • 58. Reversal of experimental renovascular hypertension.
    Edmunds ME, Russell GI, Bing RF.
    J Hypertens; 1991 Apr 09; 9(4):289-301. PubMed ID: 1646257
    [No Abstract] [Full Text] [Related]

  • 59. Interrelationship of sodium, volume, CNS, and hypertension.
    Tobian LJ.
    Prog Biochem Pharmacol; 1983 Apr 09; 19():208-29. PubMed ID: 6338523
    [No Abstract] [Full Text] [Related]

  • 60. Role of vasopressin in blood pressure control of spontaneously hypertensive rats.
    Möhring J, Kintz J, Schoun J.
    Clin Sci Mol Med Suppl; 1978 Dec 09; 4():246s-250s. PubMed ID: 282062
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.